Macitentan in Combo With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
Macitentan in Combo With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
Sponsors and Collaborators
Actelion
Contact
Charles Conrad, MD
MD Anderson Cancer Center
713-792-2883
ClinicalTrials.gov Identifier
NCT01499251